SurgLine International, Inc.

SurgLine International, Inc.

SGLN
SurgLine International, Inc.US flagOther OTC
0.00
USD
- -
- -
569,012.00Market Cap

Total Valuation

SurgLine International, Inc. carries a market capitalization of 569,012.00, placing it among publicly traded companies globally. Its enterprise value stands at 3.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap569,012.00
Enterprise Value3.22M

Share Statistics

SurgLine International, Inc. currently has 5.48B shares outstanding.

Shares Outstanding5.48B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 23.70, and the price-to-book ratio stands at 1.32.

PE RatioN/A
PS Ratio23.70
PB Ratio1.32
P/TBV Ratio-1.57
P/FCF Ratio-7.56
P/OCF Ratio-7.53

Enterprise Valuation

EV / Sales28.35
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

SurgLine International, Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -24.21, indicating conservative leverage, while an interest coverage ratio of -7.53 demonstrates limited ability to service its debt obligations.

Current Ratio0.06
Quick Ratio0.05
Debt / Equity-24.21
Debt / EBITDA-0.18
Interest Coverage-7.53

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-3,077.64
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover11.32

Stock Price Statistics

SurgLine International, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Beta (5Y)N/A
52-Week Price Change0.000003%
50-Day Moving Average0.00
200-Day Moving Average0.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, SurgLine International, Inc. generated 113,620.00 in revenue and converted that into -2.74M in net income, yielding earnings per share of 0.00. EBITDA reached -2.08M, while operating income came in at -2.08M.

Revenue113,620.00
Gross Profit39,110.00
Operating Income-2.08M
Pretax IncomeN/A
Net Income-2.74M
EBITDA-2.08M
EBIT-2.08M
Earnings Per Share (EPS)0.00

Balance Sheet

SurgLine International, Inc. holds 7,467.00 in cash and equivalents against 375,759.00 in total debt, resulting in a net debt position of 368,292.00. Total book value stands at 2.04M, with working capital of -1.55M providing operational flexibility.

Cash & Cash Equivalents7,467.00
Total Debt375,759.00
Net Debt368,292.00
Equity (Book Value)2.04M
Book Value Per Share0.00
Working Capital-1.55M

Cash Flow

SurgLine International, Inc. produced -357,444.00 in operating cash flow over the past twelve months. After subtracting -1,425.00 in capital expenditures, free cash flow totaled -358,869.00 - equivalent to 0.00 per share.

Operating Cash Flow-357,444.00
Capital Expenditures-1,425.00
Free Cash Flow-358,869.00
FCF Per Share0.00

Margins

SurgLine International, Inc. operates with a gross margin of 34.42, reflecting its pricing power and cost economics. The operating margin of -1,832.45 and net profit margin of -2,409.35 provide insight into operational efficiency.

Gross Margin34.42
Operating Margin-1,832.45
Pretax MarginN/A
Profit Margin-2,409.35
EBITDA Margin-1,831.83

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-11.73
FCF Yield-13.22

Stock Splits

SurgLine International, Inc.'s most recent stock split took place on May 21, 2002 with a 1000:529 split ratio.

Last Split Date5/21/2002
Split Ratio1000:529

Scores

SurgLine International, Inc. posts an Altman Z-Score of -126.13, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-126.13